Three independently deleted regions at chromosome arm 16q in human prostate cancer: Allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient

British Journal of Cancer

Volumn 79, Issue 1, 1999, Pages 156-160

  Elo, J P ^a   Harkonen P ^a   Kyllonen A P ^a   Lukkarinen, O ^a   Vihko, P ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

16q; 17HSD type 2; HSD17B2; Loss of heterozygosity; Prostate cancer

Indexed keywords

ARTICLE; CANCER RECURRENCE; CELL DIFFERENTIATION; CHROMOSOME 16Q; CLINICAL ARTICLE; DELETION MUTANT; FOLLOW UP; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; TUMOR DIFFERENTIATION;

ALLELES; CELL DIFFERENTIATION; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 16; HUMANS; LOSS OF HETEROZYGOSITY; MALE; NEOPLASM METASTASIS; PROGNOSIS; PROSTATIC NEOPLASMS; RECURRENCE;

EID: 0032889508     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690025     Document Type: Article

References (26)

1. Bergerheim US, Kunimi K, Collins VP and Ekman P (1991) Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chroms Cancer 3: 215-220
2. Brendler CB, Isaacs JT, Follansbee AL and Walsh PC (1984) The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate: a preliminary report. J Urol 131: 694-700
3. Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA and de la Chapelle A (1996) Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 56: 3331-3337
4. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI and Isaacs WB (1990) Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87: 8751-8755
5. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB and Jensen RH (1996) Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56: 3091-3102
6. Chisholm GD (1988) TNM classification of urologic tumours in 1988. Br J Urol 62: 501
7. Délos S, Carsol J-L, Ghazarossian E, Raynaud J-P and Martin P (1995) Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts. J Steroid Biochem Mol Biol 55: 375-383
8. Dib C, Faure S, Fizames C, Samson D, Drout N, Vignal A, Millasseau P, Marc S, Kazan J, Seboun E, Lathrop M, Gyapay G, Morrissette J and Weissenbach J (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380: 152-154
9. Durocher F, Morrisette J, Labrie Y, Labrie F and Simard J (1995) Mapping of the HSD17B2 gene encoding type II 17β-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q24.1-q24.2. Genomics 25: 724-726
10. Elo JP, Akinola LA, Poutanen M, Vihko P, Kyllönen A-P, Lukkarinen O and Vihko R (1996) Characterization of 17β-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. Int J Cancer 66: 37-41
11. Elo JP, Härkönen P, Kyllönen A-P, Lukkarinen O, Poutanen M, Vihko R and Vihko P (1997) Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res 57: 3356-3359
12. Isaacs JT (1994) Role of androgens in prostatic cancer. Vitam Horm 49: 433-502
13. Joos S, Bergerheim USR, Pan Y, Matsuyama H, Bentz M, du Manoir S and Lichter P (1995) Mapping of chromosomal gains and losses in prostate cancer by genomic hybridization. Genes Chromosomes Cancer 14: 267-276
14. Kaupmann K, Becker-Follmann J, Scherer G, Jockusch H and Starzinski-Powitz A (1992) The gene for cell adhesion molecule M-cadherin maps to mouse chromosome 8 and human chromosome 16q24.2-qter and is near the E-cadherin (Uvomorulin) locus in both species. Genomics 14: 488-490
15. Klein H, Bressel M, Kastendieck H and Voigt K-D (1991) Biochemical endocrinology of prostate cancer. In Endocrine Dependent Tumors. Voigt K-D, Knabbe K (eds), pp. 131-163. Raven Press: New York
16. Labrie Y, Durocher F, Lachance Y, Turgeon C, Simard J, Labrie C and Labrie F (1995) The human type 2 17β hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species. DNA Cell Biol 14: 849-861
17. Latil A, Cussenot O, Fournier G, Driouch K and Lidereau R (1997) Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Cancer Res 57: 1058-1062
18. Lee SW (1996) H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nature Med 2: 776-782
19. Pullman WE and Bodmer WF (1992) Cloning and characterization of a gene that regulates cell adhesion. Nature 356: 529-532
20. Ray R and Miller DM (1991) Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol 11: 2154-2161
21. Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi T, Yatani R and Shimazaki J (1996) Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancer. Genes Chroms Cancer 17: 225-233
22. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HFM, Oosterhof GON, Debruyne FMJ and Schalken JA (1994) Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54: 3929-3933
23. Visakorpi T, Kallioniemi AH, Syvänen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ and Kallioniemi OP (1995) Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55: 342-347
24. Vogelstein B and Kinzler KW (1992) p53 Function and dysfunction. Cell 70: 523-526
25. Werle E, Schneider C, Völker M and Fiehn W (1994) Convenient single-step, one tube purification of PCR products for direct sequencing. Nucleic Acids Res 22: 4354-4355
26. Wright DK and Manos MM (1990) Sample preparation from paraffin-embedded tissues. In PCR Protocols: A Guide to Methods and Applications. Innis MA, Gelfand JJ and White TJ (eds), pp. 153-158. Academic Press: San Diego